Collagen 1-mediated CXCL1 secretion in tumor cells activates fibroblasts to promote radioresistance of esophageal cancer
Cell Reports · 2023
DOI: 10.1016/j.celrep.2023.113270 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Xinyu Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Me…. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Carcinoma, Squamous Cell, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China National Funds for Distinguished Young Scientists, National Natural Science Foundation of China.
Abstract (Originalsprache)
Esophageal squamous-cell carcinoma (ESCC) is commonly treated with radiotherapy; however, radioresistance hinders its clinical effectiveness, and the underlying mechanism remains elusive. Here, we develop patient-derived xenografts (PDXs) from 19 patients with ESCC to investigate the mechanisms driving radioresistance. Using RNA sequencing, cytokine arrays, and single-cell RNA sequencing, we reveal an enrichment of cancer-associated fibroblast (CAF)-derived collagen type 1 (Col1) and tumor-cell-derived CXCL1 in non-responsive PDXs. Col1 not only promotes radioresistance by augmenting DNA repair capacity but also induces CXCL1 secretion in tumor cells. Additionally, CXCL1 further activates CAFs via the CXCR2-STAT3 pathway, establishing a positive feedback loop. Directly interfering with tumor-cell-derived CXCL1 or inhibiting the CXCL1-CXCR2 pathway effectively restores the radiosensitivity of radioresistant xenografts in vivo. Collectively, our study provides a comprehensive understanding of the molecular mechanisms underlying radioresistance and identifies potential targets to improve the efficacy of radiotherapy for ESCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing…
Förderung
- China National Funds for Distinguished Young Scientists
- National Natural Science Foundation of China
Zitieren
APA
Yang, X., Chen, X., Zhang, S., Fan, W., Zhong, C., Liu, T., Cheng, G., Zhu, L., Liu, Q., Xi, Y., Tan, W., Lin, D., & Wu, C. (2023). Collagen 1-mediated CXCL1 secretion in tumor cells activates fibroblasts to promote radioresistance of esophageal cancer. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113270
Vancouver
Yang X, Chen X, Zhang S, Fan W, Zhong C, Liu T, et al. Collagen 1-mediated CXCL1 secretion in tumor cells activates fibroblasts to promote radioresistance of esophageal cancer. Cell Reports. 2023. doi:10.1016/j.celrep.2023.113270
BibTeX
@article{Yang2023,
author = {Yang, Xinyu and Chen, Xinjie and Zhang, Shaosen and Fan, Wenyi and Zhong, Ce and Liu, Tianyuan and Cheng, Guoyu and Zhu, Liang and Liu, Qingyi and Xi, Yiyi and Tan, Wen and Lin, Dongxin and Wu, Chen},
title = {Collagen 1-mediated CXCL1 secretion in tumor cells activates fibroblasts to promote radioresistance of esophageal cancer},
journal = {Cell Reports},
year = {2023},
doi = {10.1016/j.celrep.2023.113270}
}
EUVIMED